CI

At a glance

ClinicalIndex Comparison Record
N/AActive· 20 target
Drug / intervention
Gallotannin-rich mango +2 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT07505212
NCT07505212N/AActiveMonitorCompletion was 1mo ago
Slow Enrollment

Exploring Tannin-Probiotic Interactions on Microbial Composition and Inflammatory Outcomes in Obesity

Prairie View A&M University·interventional·Posted Apr 1, 2026·Updated Jun 9, 2026

In Brief

A clinical study evaluating Gallotannin-rich mango, Lactiplantibacillus pentosus (probiotic), and 1 other intervention for Obesity (Disorder). Active but no longer recruiting, targeting 20 participants across 1 site.

Signals

Enrolling slower than its timeline implies

Detailed Summary

The goal of this clinical trial is to understand how gallotannin-rich (GT-rich) mangoes can reduce the inflammatory markers in obese individuals in vitro. The study will also seek to explore how gallotannins are metabolized in the gut microbiome. The main questions the research aims to answer are: * What is the impact of GT extract from mango and Lactiplantibacillus pentosus supplementation on inflammatory biomarkers in obese individuals? * Does the combination of GTs and L. pentosus exhibit synergistic effects in modulating specific microbial taxa associated with obesity and inflammation compared to either intervention alone? * Does genetic variation among individuals with obesity account for the ability to metabolize gallotannins? Researchers will compare the effects of GT extract from mango juice, a combination of GT-rich extract, and L. pentosus probiotic supplement on samples (stool) provided by obese individuals, to samples provided by a lean control group to see if gallotannins and gallotannins + probiotic supplementation reduce inflammation in obesity. Participants will * Be grouped into 4 treatment groups 1. Mango juice only 2. Mango + L. pentosus 3. L. pentosus only 4. Control (lean individuals) * Visit sample collection site one time during the study (week 1)

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/AActiveOverdue
First PostedApr 1, 2026
Enrollment StartApr 14, 2026
Primary CompletionJun 1, 2026
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 3 months ago

Interventions

Gallotannin-rich mangodietary

This mango is high in polyphenols, specifically hydrolysable tannins, which are easily broken down by microbes in the colon. The metabolites formed can improve the gut microbiome population and also improve immune response.

Lactiplantibacillus pentosus (probiotic)dietary

Lactiplantibacillus pentosus is a probiotic bacterium that can benefit gut health and may have additional benefits like reducing inflammation

No Treatment Addedother

This intervention has no treatment added so as to serve as a control for the other interventions.